B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation
Experimental & Molecular Medicine
; : 208-216, 2009.
Article
en En
| WPRIM
| ID: wpr-76609
Biblioteca responsable:
WPRO
ABSTRACT
B cell activation factor (BAFF) is a novel member of the TNF ligand superfamily, mainly produced by myeloid cells. BAFF has been shown to participate in B-cell survival and B- and T-cell maturation. BAFF expression in adipocytes has been recently demonstrated. In the current study, we verified that BAFF expression is increased during adipocyte differentiation. BAFF expression was augmented by TNF-alpha treatment and was decreased by rosiglitazone treatment. BAFF secretion in lean and in ob/ob mice sera were compared and smaller amount of BAFF was secreted in ob/ob mice. mRNA and protein expression were different between epididymal and visceral adipose tissue. BAFF expression was also increased in ob/ob mouse adipose tissue. We sought to identify known BAFF receptors (BAFF-R, BCMA, and TACI) in adipocytes, and determined that all three were present and upregulated during adipocyte differentiation. However, the expression of TACI was distinct from that of BAFF-R and BCMA under TNF-alpha and BAFF ligand treatment. BAFF-R and BCMA expression levels were upregulated under pro-inflammatory conditions, but TACI was reduced. Conversely, BAFF-R and BCMA expression levels were downregulated by rosiglitazone treatment, but TACI was increased. Taken together, our results suggest that BAFF may be a new adipokine, representing a link between obesity and inflammation.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Diferenciación Celular
/
Factor de Necrosis Tumoral alfa
/
Adipocitos
/
Tiazolidinedionas
/
Factor Activador de Células B
/
Receptor del Factor Activador de Células B
/
Adipoquinas
/
Hipoglucemiantes
/
Inflamación
/
Obesidad
Tipo de estudio:
Prognostic_studies
Límite:
Animals
Idioma:
En
Revista:
Experimental & Molecular Medicine
Año:
2009
Tipo del documento:
Article